Femasys Inc. FEMY NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score

41/100

2/7 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Femasys Inc. (FEMY), 포함 40 건 매수 및 1 건 매도. 내부자 매수 총액은 $1.52M 내부자 매도 총액은 $6.25M.

최근 활동이 있는 주요 내부자에는 Canning John Charles, Elefant Dov, Lee-sepsick Kathy. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — FEMY

날짜	이름	직책	거래 유형	주식수	평균 가격	금액	보유 주식수
2026-03-30	Canning John Charles	Chief Operating Officer	알 수 없음	-	-	-	30,000
2026-03-30	Canning John Charles	Chief Operating Officer	RSU 부여	150,000	$0.38	$57K	150,000
2026-03-19	Elefant Dov	Chief Financial Officer	RSU 부여	34,122	$0.58	$19.79K	34,122
2026-03-19	Lee-sepsick Kathy	Chief Executive Officer	RSU 부여	68,244	$0.58	$39.58K	68,244
2026-03-19	Larsen Charles	Director	RSU 부여	34,122	$0.58	$19.79K	34,122
2026-03-19	Eichenbaum Kenneth D.	Director	RSU 부여	102,366	$0.58	$59.37K	102,366
2026-03-18	Eichenbaum Kenneth D.	Director	RSU 부여	35,200	$0.60	$21.12K	35,200
2026-03-18	Eichenbaum Kenneth D.	Director	알 수 없음	-	-	-	25,010
2026-03-17	Pharmacyte Biotech, Inc.	10 Percent Owner	알 수 없음	-	-	-	-
2026-03-17	Silverman Joshua	Director	알 수 없음	-	-	-	-
2026-02-19	Elefant Dov	Chief Financial Officer	RSU 부여	169,000	-	-	169,000
2026-02-19	Lee-sepsick Kathy	Chief Executive Officer	RSU 부여	282,000	-	-	282,000
2026-02-02	Sipos Jeremy Alexander	Chief Technology Officer	RSU 부여	80,000	-	-	80,000
2025-12-16	Sipos Jeremy Alexander	Chief Technology Officer	알 수 없음	3,334	$6.12	$20.4K	-
2025-11-07	Elefant Dov	Chief Financial Officer	임의 매수	-	$0.73	-	-
2025-11-07	Larsen Charles	Director	임의 매수	-	$0.73	-	-
2025-11-07	Lee-sepsick Kathy	Chief Executive Officer	임의 매수	-	$0.73	-	-
2025-11-07	Eichenbaum Kenneth D.	Director	알 수 없음	102,366	$1.10	$112.6K	-
2025-08-27	Elefant Dov	Chief Financial Officer	임의 매수	38,828	$0.52	$20K	38,828
2025-08-27	Lee-sepsick Kathy	Chief Executive Officer	임의 매수	48,535	$0.52	$25K	48,535
2025-06-25	Silverman Joshua	Director	RSU 부여	17,600	$0.98	$17.25K	17,600
2025-06-25	Uzialko Edward R	Director	RSU 부여	17,600	$0.98	$17.25K	17,600
2025-06-25	Larsen Charles	Director	RSU 부여	17,600	$0.98	$17.25K	17,600
2025-06-25	Milnes Alistair	Director	RSU 부여	17,600	$0.98	$17.25K	17,600
2025-06-23	Nicholas Kelley Stinson	Chief Commercial Officer	알 수 없음	-	-	-	45
2025-06-23	Nicholas Kelley Stinson	Chief Commercial Officer	RSU 부여	100,000	$0.90	$90K	100,000
2025-06-02	Elefant Dov	Chief Financial Officer	임의 매수	19,608	$1.02	$20K	19,608
2025-06-02	Lee-sepsick Kathy	Chief Executive Officer	임의 매수	34,314	$1.02	$35K	312,092
2025-06-02	Currie Daniel Scott	Chief Operating Officer	임의 매수	19,608	$1.02	$20K	86,275
2025-06-02	Larsen Charles	Director	임의 매수	24,510	$1.02	$25K	56
2025-01-29	Lee-sepsick Kathy	Chief Executive Officer	RSU 부여	59,849	$1.17	$70.02K	59,849
2025-01-28	Elefant Dov	Chief Financial Officer	RSU 부여	72,045	$1.05	$75.65K	72,045
2025-01-28	Currie Daniel Scott	Chief Operating Officer	RSU 부여	29,184	$1.05	$30.64K	29,184
2025-01-28	Thomas Christine E	Chief Reg & Clinical Officer	RSU 부여	23,600	$1.05	$24.78K	23,600
2024-07-12	Silverman Joshua	Director	RSU 부여	17,600	$1.14	$20.06K	17,600
2024-07-12	Uzialko Edward R	Director	RSU 부여	17,600	$1.14	$20.06K	17,600
2024-07-12	Larsen Charles	Director	RSU 부여	17,600	$1.14	$20.06K	17,600
2024-07-12	Milnes Alistair	Director	RSU 부여	17,600	$1.14	$20.06K	17,600
2024-02-12	Spector Richard D.	Officer	알 수 없음	-	-	-	-
2024-02-12	Spector Richard D.	Chief Commercial Officer	RSU 부여	100,000	$1.10	$110K	100,000
2024-02-01	Elefant Dov	Chief Financial Officer	RSU 부여	84,000	$0.80	$67.2K	84,000
2024-02-01	Lee-sepsick Kathy	Chief Executive Officer	RSU 부여	204,900	$0.80	$163.92K	204,900
2024-02-01	Currie Daniel Scott	Chief Operating Officer	RSU 부여	61,900	$0.80	$49.52K	61,900
2024-02-01	Thomas Christine E	SVP, Regulatory & Clinical	RSU 부여	32,600	$0.80	$26.08K	32,600
2023-11-21	Silverman Joshua	Officer	알 수 없음	-	-	-	-
2023-11-21	Silverman Joshua	Director	RSU 부여	17,000	$0.90	$15.3K	17,000
2023-11-21	Pharmacyte Biotech, Inc.	10 Percent Owner	처분	4,237,288	$1.48	$6.25M	-
2023-10-10	Thomas Christine E	SVP, Regulatory & Clinical	RSU 부여	60,000	$1.76	$105.6K	60,000
2023-07-03	Elefant Dov	Chief Financial Officer	RSU 부여	105,200	$0.49	$51.55K	105,200
2023-07-03	Lee-sepsick Kathy	Chief Executive Officer	RSU 부여	270,400	$0.49	$132.5K	270,400